1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Antineoplastic Agents: new trials by email Literature Review of Antineoplastic Agents trials Research Report on Antineoplastic Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. Palonosetron, Ondansetron - Breast Neoplasm, Antineoplastic Agents | Phase 2 / Phase 3 | Unknown | Instituto Nacional de Cancerologia de Mexico | 560 | 2015-11-05 | 2018-07-30 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Ondansetron (1) · Palonosetron (1)
Instituto Nacional de Cancerologia de Mexico (1)
Mexico (1)
Claudia H Arce Salinas, MD (1)
PMID 11226762, PMID 12686700, PMID 12697943, PMID 1352024, PMID 15139073, PMID 16766588, PMID 17187507, PMID 17530482, PMID 18525044, PMID 19037667, PMID 20972805, PMID 21533811, PMID 22488022, PMID 23358260, PMID 24761161, PMID 25012726, PMID 25106522, PMID 3281702, PMID 3544842, PMID 6681766, PMID 9789602